Although the GOP's plan to repeal the Affordable Care Act industry taxes died with the party's health care bill, it's conventional wisdom that some of the taxes will still be delayed. But there's no plan to do so yet.
Lobbying campaigns to repeal or delay the health insurance tax and the medical device tax are ramping up, yet there's no clear vehicle for Congress to take action. Well-wired lobbyists and Hill aides say the appetite for doing anything major on health care isn't really there.
"It is a have-to-get-done that's really hard to get done," said one lobbyist.
Brand-name pharmaceutical companies and health insurers increased their profits in the second quarter of this year, while hospitals and drug distributors had a more difficult run, according to a review of financial documents for 58 publicly traded health care companies.
Between the lines: Drug companies continue to raise their list prices for branded drugs despite the public furor, so they naturally maintained their status as the most profitable sector in health care. Insurers also collected higher profits because fewer people are going to the hospital or doctor, which results in more money staying in their pockets.
Data: Securities and Exchange Commission filings; Chart: Andrew Witherspoon / Axios